A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Vaccine

• Publication date

  2006-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2006.04.036PMID 16730864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein and Antigenic Variability among Mycoplasma hyopneumoniae Strains by SDS-PAGE and Immunoblot

  2005cited by this paper
• Proteolytic Processing of the Mycoplasma hyopneumoniae Cilium Adhesin

  2004cited by this paper
• Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.

  2004cited by this paper
• Construction of prokaryotic expression system of ltB-ureB fusion gene and identification of the recombinant protein immunity and adjuvanticity.

  2004cited by this paper
• Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B

  2003cited by this paper
• Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method.

  2003cited by this paper
• Expression and Immunogenicity of Mycoplasma hyopneumoniae Heat Shock Protein Antigen P42 by DNA Vaccination

  2003cited by this paper
• Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus.

  2002cited by this paper
• Erysipelothrix rhusiopathiae YS-1 as a Live Vaccine Vehicle for Heterologous Protein Expression and Intranasal Immunization of Pigs

  2002cited by this paper
• Escherichia coli Heat-Labile Enterotoxin B Subunit Is a More Potent Mucosal Adjuvant than Its Closely Related Homologue, the B Subunit of Cholera Toxin

  2001cited by this paper
• Immunomodulation Using Bacterial Enterotoxins

  2001cited by this paper
• A recombinant chimera composed of repeat region RR1 of Mycoplasma hyopneumoniae adhesin with Pseudomonas exotoxin: in vivo evaluation of specific IgG response in mice and pigs.

  2001cited by this paper
• Protective Mucosal Immunity to Ocular Herpes Simplex Virus Type 1 Infection in Mice by Using Escherichia coli Heat-Labile Enterotoxin B Subunit as an Adjuvant

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Genetically Manipulated Bacterial Toxin as a New Generation Mucosal Adjuvant

  2001cited by this paper
• Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.

  2000cited by this paper
• Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pyloriInfection

  2000cited by this paper
• R1 Region of P97 Mediates Adherence ofMycoplasma hyopneumoniae to Swine Cilia

  2000cited by this paper
• Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein.

  1999cited by this paper
• Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit

  1998cited by this paper
• Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins

  1998cited by this paper
• A plant-based cholera toxin B subunit–insulin fusion protein protects against the development of autoimmune diabetes

  1998cited by this paper
• Identification of the Cilium Binding Epitope of theMycoplasma hyopneumoniae P97 Adhesin

  1998cited by this paper
• Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF)

  1997cited by this paper
• Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.

  1997cited by this paper
• Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin

  1997cited by this paper
• Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential.

  1997cited by this paper
• Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity

  1997cited by this paper
• Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.

  1996cited by this paper
• Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

  1995cited by this paper
• Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections.

  1995cited by this paper
• Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes.

  1995cited by this paper
• Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit.

  1994cited by this paper
• Microtiter plate adherence assay and receptor analogs for Mycoplasma hyopneumoniae

  1994cited by this paper
• Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures

  1994cited by this paper
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

  1994cited by this paper
• Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines

  1993cited by this paper
• Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice

  1993cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activity

  1992cited by this paper
• Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli

  1991cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library

  1985cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Identification and Characterization of a Mycoplasma hyopneumoniae Adhesin

  year unknowncited by this paper

• CD40 Ligand Potentiates Immunogenecity of Mycoplasma pneumoniae Subunit Vaccine Candidate in a Murine Model

  2025cites this paper
• Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs.

  2025cites this paper
• Escherichia coli Heat-Labile Enterotoxin B Subunit as an Adjuvant of mucosal Immune Combined with GCRV-II VP6 Triggers Innate Immunity and Enhances Adaptive Immune Responses Following Oral Vaccination of Grass Carp (Ctenopharyngodon idella).

  2024cites this paper
• Chimeric proteins of Mycoplasma hyopneumoniae as vaccine and preclinical model for immunological evaluation

  2024cites this paper
• Characterization of the pig lower respiratory tract antibiotic resistome

  2023cites this paper
• Immunogenicity of an inactivated vaccine for intravaginal application against bovine alphaherpesvirus type 5 (BoHV-5).

  2023cites this paper
• Development of a Multi-Epitope Vaccine for Mycoplasma hyopneumoniae and Evaluation of Its Immune Responses in Mice and Piglets

  2022cites this paper
• Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine

  2021cites this paper
• Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs

  2021cites this paper
• Evaluation of Immunogenicity and Efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) Fused to E. coli Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle

  2021cites this paper
• Current Status for Controlling the Overlooked Caprine Fasciolosis

  2021cites this paper
• Immunocontraceptive potential of a recombinant chimeric protein composed by a single gonadotropin-releasing hormone molecule and B subunit of Escherichia coli heat-labile enterotoxin in a mice model

  2020influential citation
• Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2

  2020cites this paper
• Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae

  2019cites this paper
• Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System

  2019cites this paper
• Instructions for use Title Protection against Pasteurella multocida conferred by an intranasal fowl cholera vaccine in Khaki

  2019cites this paper
• Immunoenhancement of recombinant Neisseria meningitides PorB protein on porcine circovirus type 2 and Mycoplasma hyopneumo-niae genetically engineered vaccines.

  2019cites this paper
• Protection Efficacy of the rLTB-R1 Chimera against Experimental Swine Mycoplasmal Pneumonia

  2019cites this paper
• Analysis of swine antigen-specific antibody responses to Mycoplasma hyopneumoniae infection determined by protein microarray.

  2019cites this paper
• A concise review of vaccines against Mycoplasma hyopneumoniae.

  2019cites this paper
• Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control

  2018cites this paper
• Molecular characterization of the recombinant protein RmLTI-BmCG-LTB: Protective immunity against Rhipicephalus (Boophilus) microplus

  2018cites this paper
• Protection against Pasteurella multocida conferred by an intranasal fowl cholera vaccine in Khaki Campbell ducks

  2018cites this paper
• A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.

  2017cites this paper
• Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin

  2017influential citation
• Imunogenicidade da proteína M recombinante de Streptococcus equi subsp. equi coadministrada com um adjuvante molecular

  2017cites this paper
• Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice

  2016cites this paper
• Commercial bacterins did not induce detectable levels of antibodies in mice against Mycoplasma hyopneumoniae antigens strongly recognized by swine immune system

  2016cites this paper
• Mycoplasma hyorhinis disease model, proteomics, and vaccine efficacy

  2016cites this paper
• Development of Mycoplasma hyopneumoniae Recombinant Vaccines.

  2016cites this paper
• Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines

  2016cites this paper
• Evaluation of a multi-epitope subunit vaccine against avian leukosis virus subgroup J in chickens.

  2015cites this paper
• Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs

  2015cites this paper
• Comparison of a live attenuated Salmonella Enteritidis vaccine candidate secreting Escherichia coli heat-labile enterotoxin B subunit with a commercial vaccine for efficacy of protection against internal egg contamination by Salmonella in hens.

  2015cites this paper
• Mycoplasma hyopneumoniae: clinical, pathological and host inflammatory responses to infection and vaccine development

  2014influential citation
• Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection.

  2014cites this paper
• Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions.

  2014influential citation
• Salmonella enterica Serovar Enteritidis Ghosts Carrying the Escherichia coli Heat-Labile Enterotoxin B Subunit Are Capable of Inducing Enhanced Protective Immune Responses

  2014cites this paper
• Characterization of a Salmonella Typhimurium ghost carrying an adjuvant protein as a vaccine candidate for the protection of chickens against virulent challenge

  2014cites this paper
• Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.

  2014cites this paper
• Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.

  2014cites this paper
• A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses

  2014cites this paper
• Immune Responses Capable of Inducing Enhanced Protective Heat-Labile Enterotoxin B Subunit Are Ghosts Carrying the Escherichia coli Salmonella enterica Serovar Enteritidis

  2014cites this paper
• Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.

  2014cites this paper
• Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens

  2014cites this paper
• Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine

  2013cites this paper
• Adjuvant effect of Escherichia coli heat labile enterotoxin B subunit against internal egg contamination in domestic fowl immunised with a live Salmonella enterica serovar Enteritidis vaccine.

  2013cites this paper
• Enhanced protective immune responses against Salmonella Enteritidis infection by Salmonella secreting an Escherichia coli heat-labile enterotoxin B subunit protein.

  2013cites this paper
• Production and Evaluation of a Recombinant Chimeric Vaccine against Clostridium botulinum Neurotoxin Types C and D

  2013cites this paper
• Immunologic Effect of Attenuated Salmonella enteric Serovar Choleraesuis C501 Expressing Recombinant Mycoplasma hyopneumoniae P97R1 Adhesin and NrdF Antigens in Mice

  2013cites this paper
• Immune responses following vaccination of pigs and mice against Mycoplasma hyopneumoniae

  2013influential citation
• Mycoplasma hyopneumoniae: from disease to vaccine development.

  2013cites this paper
• UNIVERSIDADE FEDERAL DE PELOTAS Programa de Pós-Graduação em Veterinária

  2012cites this paper
• Molecular and functional characterisation of p97 and p102 paralogue family members of mycoplasma hyopneumoniae

  2012influential citation
• Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat

  2012cites this paper
• Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines.

  2012cites this paper
• Production and characterization of Clostridium perfringens recombinant β toxoid.

  2012cites this paper
• Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins.

  2012cites this paper
• Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.

  2012cites this paper
• Resposta imune induzida por antígenos de Mycoplasmahyopneumoniae avaliados como vacina de DNA ou subunidade recombinante.

  2011cites this paper
• Non-toxic derivatives of LT as potent adjuvants.

  2011cites this paper
• Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route

  2010influential citation
• Construction and evaluation of chimeric heat-labile toxin B subunit and N-terminal(1–75) fragment of colonization factor antigen I gene of enterotoxigenic Escherichia coli

  2010influential citation
• Identification and characterisation of immunoreactive antigens of mycoplasma hyopneumoniae

  2010cites this paper
• Efficient site-directed mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli.

  2009cites this paper
• Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library.

  2009cites this paper
• Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display

  2008cites this paper
• The development of non antibiotic resistant recombinant vaccines against mycoplasma hyopneumoniae

  2008cites this paper
• B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination.

  2008cites this paper
• Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice.

  2008cites this paper
• Vaccine Development Using Recombinant DNA Technology Animal Agriculture ’ s Future through Biotechnology

  2008cites this paper
• Immune Responses Induced by Replication-Defective Adenovirus Expressing the C-Terminal Portion of the Mycoplasma hyopneumoniae P97 Adhesin

  2007cites this paper
• Proteomic survey of the pathogenic Mycoplasma hyopneumoniae strain 7448 and identification of novel post-translationally modified and antigenic proteins.

  2007cites this paper